Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.

  title={Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.},
  author={Jamie Mells and Ping P. Fu and Pradeep Kumar and Tekla D. Smith and Saul J. Karpen and Frank A Anania},
  journal={The Journal of nutritional biochemistry},
  volume={26 3},

Figures and Tables from this paper

Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet

It is demonstrated that hamsters rapidly develop dyslipidemia when fed a high-fat, high-fructose, high -cholesterol diet, and within four to eight months, the NASH-diet induced hepatic changes with resemblance to human NAFLD.

High fat diet mouse model in the study of nonalcoholic fatty liver disease and hepatocellular carcinoma

Long-term high-fat (HF) diet consumption is one of the risk factors of NAFLD and feeding HF diet is widely used to produce hepatic steatosis and NASH in experimental animals, and the current application of HF diet mouse model on the study ofNAFLD/NASH and HCC is focused on.

Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague–Dawley rats

These findings show that dietary fat and cholesterol are the primary drivers of NAFLD development and progression in rats, while fructose mostly exerts its effect on the circulating lipid pool.

Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights.

Several studies conducted within the last 5 years that used MCD diet or WD mouse models in order to mimic this disease in a way most similar to humans are reviewed, finding these choices most suitable for research.

A high-trans fat, high-carbohydrate, high-cholesterol diet-induced nonalcoholic steatohepatitis mouse model and its hepatic immune response

The constructed model closely approximated the characteristics of human NASH and evaluation of its immune response signature, showed that the innate immune response was more pronounced than adaptive immunity.

Dietary cholesterol induces hepatic inflammation and blunts mitochondrial function in the liver of high-fat-fed mice.

Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development

Most current guidelines recommend low-calorie, plant-based diets, such as the Mediterranean diet, as the most effective dietary pattern to treat NAFLD, however, more clinical trials are required to identify the best evidence-based dietary treatment approach.

Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet–fed mice

It is suggested that blocking ASBT function with a luminally restricted apical sodium-dependent BA transporter (ASBT) inhibitor can improve both hepatic and whole body aspects of NAFLD.



Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis

Dietary fat and dietary cholesterol interact synergistically to induce the metabolic and hepatic features of NASH, whereas neither factor alone is sufficient to cause NASH in mice.

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.

It was established that trans fats played a major role in promoting hepatic steatosis and injury, whereas inclusion of HFCS promoted food consumption, obesity, and impaired insulin sensitivity, and their role in the epidemic of NASH needs further evaluation.

Good fat/bad fat

A more complex model of steatosis was used, employing db/db mice fed a methionine-restricted, choline-deficient (MCD) diet, and there was some optimism that blocking DGAT2, which catalyzes the final step in hepatic triglyceride production, may be beneficial in NAFLD/NASH.

Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS‐55

Examination of the effects of HFCS‐55 on hepatocyte lipogenesis, insulin signaling, and cellular function, in vitro and in vivo, indicates a potential mechanism by which HFCs‐55 may contribute to the pathogenesis of NAFLD.

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

Findings indicate that dietary cholesterol, possibly in the form of modified plasma lipoproteins, is an important risk factor for the progression to hepatic inflammation in diet‐induced NASH.

Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.

Taking all together, NAFLD has become the third most important indication for liver transplantation and training programmes in internal medicine, gastroenterology and hepatology should stress the importance of diagnosing and treating properly those at risk for developing complications of portal hypertension and concomitant cardiovascular disease.

Dysfunctional very‐low‐density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis

A growing body of literature suggests that a deterioration in fatty acid oxidation and V LDL secretion from the liver, caused by the impediment of VLDL synthesis, might induce serious lipid oxidation and DNA oxidative damage, impacting the degree of liver injury and thereby contributing to the progression of NASH.